HPV Reduced Dose Schedule Just as Effective as Standard Dose
August 10th 2016A new study found that girls between 9 and 14 years of age who received a two-dose HPV-16/18 AS04-adjuvanted vaccine over a 6 or 12-month period of time are just as protected from HPV as girls between 15 and 25 years of age who received a three-dose vaccine over the course of 6 months.
Fear of Ebola Drives Liberian Women Away from Healthcare Facilities
August 8th 2016The first household survey was conducted in Liberia to examine the collateral harm to maternal healthcare delivery services in areas impacted by the Ebola epidemic. It showed that since the Ebola epidemic began, facility-based deliveries have declined mostly due to fear of acquiring infection, keeping women away from using the healthcare services available to them.
HIV Prevention Strategies Require Wide-scale Changes to Ensure Mortality Rates Continue to Decrease
August 7th 2016Although several ambitious initiatives intended to put an end to the AIDS epidemic have been developed and implemented, this laudable goal will be difficult to achieve without substantial and wide-scale changes in HIV prevention strategies.
Rapid CRP tests reduce antibiotic misuse & development of antibiotic resistance
August 5th 2016Researchers from the Oxford University Clinical Research Unit have found that a 5-minute CRP test can assist in the ongoing fight against antibiotic resistance by reducing antibiotic misuse for respiratory infections.
New RNA Vaccines May Reduce Disease Outbreak Response Time
August 3rd 2016Engineers at the Massachusetts Institute of Technology have developed a new type of customizable vaccines using messenger RNA that has proven to effectively combat a wide range of lethal pathogens when administered to mice, and might be able to reduce disease outbreak response time in the future.
Increasing Zika Transmission in Puerto Rico and Florida Prompts Additional CDC Funding
August 2nd 2016The rapid spread of Zika throughout Puerto Rico coupled with the introduction of active transmission in Florida has prompted the Centers for Disease Control and Prevention (CDC) to award millions in Zika funding to US states and territories.
World's Largest Partnership Formed to Fight Antimicrobial Resistance
August 1st 2016The world’s largest public-private partnership has been formed in a collective effort to battle antimicrobial resistance through a global project, CARB-X, which will be comprised of expert product developers who will research and develop new antimicrobial products.